Dock (Rumex crispus)

Dock (Rumex crispus) contains nepodin compounds that demonstrate antimalarial activity with IC50 values of 151.4-161.6 μg/mL against Plasmodium falciparum. The plant exhibits antibacterial properties through anthraquinone derivatives that disrupt bacterial cell wall synthesis.

Category: European Evidence: 2/10 Tier: Preliminary (in-vitro/animal)
Dock (Rumex crispus) — Hermetica Encyclopedia

Origin & History

Dock (Rumex crispus), also known as yellow dock or curly dock, is a perennial herb native to Europe and naturalized worldwide, belonging to the Polygonaceae family. The roots are harvested, dried, and typically extracted using solvents like ethanol, methanol, or dichloromethane to obtain bioactive compounds including anthraquinone glycosides, tannins, and flavonoids.

Historical & Cultural Context

In European and Native American herbalism, yellow dock root has been used for centuries as a blood purifier, tonic, laxative, and astringent for constipation, skin conditions, and anemia. It served as a mild purgative, antiscorbutic, and depurative remedy, with usage documented in historical pharmacopeias.

Health Benefits

• May support antimalarial activity through nepodin compounds (preliminary evidence from in vitro studies showing IC50 values of 161.6-151.4 μg/mL against Plasmodium falciparum)
• Demonstrates antibacterial properties against pathogens like Bacillus cereus and Pseudomonas syringae (in vitro evidence only)
• Shows potential anticancer activity in cell lines including HCT116 and MCF-7 (preliminary laboratory studies)
• Contains bioavailable iron (30 mg/100g) that may support traditional use for anemia (no clinical validation)
• Exhibits antioxidant effects through high phenolic content including cardamonin at 74.0 mg/g dry weight (preclinical evidence)

How It Works

Dock's nepodin compounds interfere with Plasmodium falciparum parasites by disrupting cellular metabolism at concentrations of 151.4-161.6 μg/mL. The anthraquinone derivatives inhibit bacterial cell wall synthesis by targeting peptidoglycan formation. These compounds also demonstrate membrane-disrupting activity against gram-positive bacteria like Bacillus cereus.

Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Rumex crispus in the research. Evidence is limited to preclinical in vitro and animal studies examining antimicrobial, antioxidant, anticancer, and antimalarial effects, with no PMIDs for human trials available.

Clinical Summary

Current evidence for dock comes primarily from in vitro studies examining antimalarial and antibacterial properties. Laboratory studies show nepodin compounds achieve IC50 values of 151.4-161.6 μg/mL against Plasmodium falciparum parasites. Antibacterial activity has been demonstrated against Bacillus cereus and Pseudomonas syringae in controlled laboratory conditions. Human clinical trials are lacking, limiting the translation of these preliminary findings to therapeutic applications.

Nutritional Profile

Dock (Rumex crispus) leaves provide approximately 20-25 kcal per 100g fresh weight. Macronutrients: protein 2.0-2.5g/100g, carbohydrates 3.0-3.5g/100g, dietary fiber 2.5-3.0g/100g, fat 0.5-0.7g/100g. Key vitamins: vitamin C approximately 48-60mg/100g (notably high, though heat-sensitive and significantly reduced by cooking), vitamin A precursors (beta-carotene) approximately 2000-2500 μg/100g, vitamin K1 approximately 300-400 μg/100g, thiamine (B1) ~0.04mg/100g, riboflavin (B2) ~0.08mg/100g. Minerals: iron 2.0-2.4mg/100g (however bioavailability is substantially reduced by high oxalic acid content of 300-700mg/100g, which binds iron and calcium into insoluble oxalates), calcium 44-60mg/100g (similarly oxalate-bound, reducing net absorption), potassium approximately 390-420mg/100g (relatively bioavailable), magnesium ~50mg/100g, phosphorus ~60mg/100g. Bioactive compounds: oxalic acid 300-700mg/100g (primary antinutrient; contraindicated in individuals with kidney stones or gout), anthraquinone glycosides including emodin and chrysophanol ~0.1-0.3% dry weight (contribute to laxative effect), nepodin (naphthalene derivative) identified as key antimalarial compound, tannins approximately 1.5-3.0% dry weight (condensed and hydrolysable forms contributing astringency and antibacterial properties), flavonoids including quercetin and hyperoside ~0.3-0.8% dry weight, stilbenoids. Bioavailability notes: the high oxalate content is the dominant bioavailability concern, significantly limiting calcium and iron absorption from this source; blanching or boiling and discarding cooking water reduces oxalate content by approximately 30-50%; not recommended as a primary mineral source despite apparent mineral richness on paper.

Preparation & Dosage

No clinically studied dosage ranges have been established for humans. Preclinical studies used 70% ethanol root extracts for antimalarial research and various solvent extracts containing up to 74 mg/g dry weight phenolics, but human dosing remains unspecified. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Iron supplements, vitamin C, dandelion root, burdock root, nettle leaf

Safety & Interactions

Dock contains oxalates and anthraquinones that may cause gastrointestinal irritation, diarrhea, and electrolyte imbalances with excessive use. The plant may interact with anticoagulant medications due to potential effects on vitamin K absorption. High oxalate content contraindicated in individuals with kidney stones or renal dysfunction. Pregnancy and breastfeeding safety data is insufficient, requiring caution during these periods.